Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus H Heim

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Journal of Virology|October 23, 2009
Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptationMaria Ripoli, Annamaria D'Aprile, Giovanni Quarato, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Plos One|July 23, 2020
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A proteaseHuong T L Tran, Kenichi Morikawa, Anggakusuma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Journal of Gastroenterology and Hepatology|January 5, 2017
Liver damage and senescence increases in patients developing hepatocellular carcinomaSilvia Rey, Cristina Quintavalle, Katharina Burmeister, et al.
Cell Reports. Medicine|November 29, 2021
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolizationTuyana Boldanova, Geoffrey Fucile, Jan Vosshenrich, et al.
Hepatology (Baltimore, Md.)|March 23, 2013
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alphaJoachim Lupberger, François H T Duong, Isabel Fofana, et al.
Life Science Alliance|November 7, 2020
Interferon lambda 4 can directly activate human CD19<sup>+</sup> B cells and CD8<sup>+</sup> T cellsMairene Coto-Llerena, Marco Lepore, Julian Spagnuolo, et al.
The Journal of Experimental Medicine|April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesFrancois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.
Journal of Virology|October 23, 2009
Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptationMaria Ripoli, Annamaria D'Aprile, Giovanni Quarato, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Plos One|July 23, 2020
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A proteaseHuong T L Tran, Kenichi Morikawa, Anggakusuma, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Journal of Gastroenterology and Hepatology|January 5, 2017
Liver damage and senescence increases in patients developing hepatocellular carcinomaSilvia Rey, Cristina Quintavalle, Katharina Burmeister, et al.
Cell Reports. Medicine|November 29, 2021
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolizationTuyana Boldanova, Geoffrey Fucile, Jan Vosshenrich, et al.
Hepatology (Baltimore, Md.)|March 23, 2013
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alphaJoachim Lupberger, François H T Duong, Isabel Fofana, et al.
Life Science Alliance|November 7, 2020
Interferon lambda 4 can directly activate human CD19<sup>+</sup> B cells and CD8<sup>+</sup> T cellsMairene Coto-Llerena, Marco Lepore, Julian Spagnuolo, et al.
The Journal of Experimental Medicine|April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapiesFrancois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Pageof 15